Thymosin Alpha-1 10MG

Description

What is Thymosin Alpha-1?

Thymosin alpha-1 is a 28-amino-acid peptide initially isolated from thymic tissue. It is investigated in laboratory studies of immune signalling and cellular responses.

Check the supplier specification and any available batch-specific analytical documentation for identity, composition and suitability for your laboratory method.

Published study findings and evidence limits

Human evidence — indication-specific and mixed

Thymosin alpha-1 has been investigated as an adjunct in immune-related conditions. A large placebo-controlled phase 3 sepsis trial found no clear reduction in 28-day all-cause mortality. No general immune-boosting, infection-prevention or longevity benefit is claimed for this listing.

Sources: TESTS phase 3 sepsis trial (2025).

Are benefits proven for this product? No clinical benefit has been established for the research material sold in this listing. Positive results for a characterised study formulation do not validate this batch, its safety or its suitability for human use. Research findings are provided for scientific context.

For research purposes only. Supplied exclusively for laboratory research and analytical use. Not for human or animal consumption, injection, therapeutic, diagnostic or cosmetic use. This product is not supplied as a medicine, food or dietary supplement. Information on this page describes research context and does not establish safety or efficacy for use in people or animals.